{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=H5N1+Influenza&page=4", "query": { "condition": "H5N1 Influenza", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 113, "total_pages": 12, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=H5N1+Influenza&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=H5N1+Influenza&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T03:30:10.300Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01594320", "title": "A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza (Pandemic)" ], "interventions": [ { "name": "Monovalent Avian Influenza VLP (H5N1)", "type": "BIOLOGICAL" }, { "name": "Monovalent Avian Influenza VLP (H5N1); Adjuvant", "type": "BIOLOGICAL" }, { "name": "Saline placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 333, "start_date": "2012-04", "completion_date": "2013-08", "has_results": false, "last_update_posted_date": "2014-02-06", "last_synced_at": "2026-10-08T03:30:10.300Z", "location_count": 5, "location_summary": "Anaheim, California • Miami, Florida • Pembroke Pines, Florida + 2 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Pembroke Pines", "state": "Florida" }, { "city": "Lenexa", "state": "Kansas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01594320" }, { "nct_id": "NCT00230750", "title": "Inactivated Influenza A/H5N1 Vaccine in the Elderly", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Influenza A/H5N1 Vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 261, "start_date": "2005-10", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2013-08-23", "last_synced_at": "2026-10-08T03:30:10.300Z", "location_count": 4, "location_summary": "Torrance, California • Rochester, New York • Cincinnati, Ohio + 1 more", "locations": [ { "city": "Torrance", "state": "California" }, { "city": "Rochester", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00230750" }, { "nct_id": "NCT01310413", "title": "Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza", "Influenza Vaccines" ], "interventions": [ { "name": "Influenza A (H5N1) Virus monovalent vaccine", "type": "BIOLOGICAL" }, { "name": "Saline placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Months to 17 Years" }, "enrollment_count": 842, "start_date": "2011-03-07", "completion_date": "2014-01-26", "has_results": true, "last_update_posted_date": "2021-11-01", "last_synced_at": "2026-10-08T03:30:10.300Z", "location_count": 11, "location_summary": "Paramount, California • Sacramento, California • Newton, Kansas + 8 more", "locations": [ { "city": "Paramount", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Newton", "state": "Kansas" }, { "city": "Bardstown", "state": "Kentucky" }, { "city": "Metairie", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01310413" }, { "nct_id": "NCT00812019", "title": "Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_0%MF59", "type": "BIOLOGICAL" }, { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_25%MF59", "type": "BIOLOGICAL" }, { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_50%MF59", "type": "BIOLOGICAL" }, { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_100%MF59", "type": "BIOLOGICAL" }, { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_0%MF59", "type": "BIOLOGICAL" }, { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_25%MF59", "type": "BIOLOGICAL" }, { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_50%MF59", "type": "BIOLOGICAL" }, { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_100%MF59", "type": "BIOLOGICAL" }, { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_0%MF59", "type": "BIOLOGICAL" }, { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_25%MF59", "type": "BIOLOGICAL" }, { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_50%MF59", "type": "BIOLOGICAL" }, { "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_100%MF59", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Seqirus", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 753, "start_date": "2008-11", "completion_date": "2010-11", "has_results": false, "last_update_posted_date": "2020-08-24", "last_synced_at": "2026-10-08T03:30:10.300Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00812019" }, { "nct_id": "NCT00776711", "title": "Vaccine for Prevention of Bird Flu", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005", "type": "DRUG" }, { "name": "VRC-AViDNA036-00-VP", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 60, "start_date": "2008-10-16", "completion_date": "2011-01-14", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-10-08T03:30:10.300Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00776711" }, { "nct_id": "NCT00532792", "title": "A/H5N1 Dose Ranging Study With Adjuvant Patch", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pandemic Influenza" ], "interventions": [ { "name": "A/H5N1", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Intercell USA, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 501, "start_date": "2007-08", "completion_date": "2008-06", "has_results": false, "last_update_posted_date": "2012-03-14", "last_synced_at": "2026-10-08T03:30:10.300Z", "location_count": 5, "location_summary": "Vallejo, California • Miami, Florida • Kansas City, Kansas + 2 more", "locations": [ { "city": "Vallejo", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Salt Lake City", "state": "Utah" }, { "city": "Tacoma", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00532792" }, { "nct_id": "NCT03738241", "title": "2017 A/H7N9 IIV Revaccination", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Avian Influenza", "Influenza Immunisation" ], "interventions": [ { "name": "A/H7N9", "type": "BIOLOGICAL" }, { "name": "AS03", "type": "DRUG" }, { "name": "Phosphate Buffered Saline (PBS) diluent", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "19 Years to 70 Years" }, "enrollment_count": 304, "start_date": "2018-12-18", "completion_date": "2020-06-19", "has_results": true, "last_update_posted_date": "2021-07-30", "last_synced_at": "2026-10-08T03:30:10.300Z", "location_count": 9, "location_summary": "Atlanta, Georgia • Iowa City, Iowa • Baltimore, Maryland + 6 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03738241" }, { "nct_id": "NCT03581903", "title": "A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "H7N3 pLAIV", "type": "BIOLOGICAL" }, { "name": "H7N9 pIIV", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 20, "start_date": "2017-09-19", "completion_date": "2019-02-06", "has_results": false, "last_update_posted_date": "2019-03-25", "last_synced_at": "2026-10-08T03:30:10.300Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03581903" }, { "nct_id": "NCT01999842", "title": "Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Investigational H7N9 vaccine GSK3206641A", "type": "BIOLOGICAL" }, { "name": "Investigational H7N9 vaccine GSK3206640A", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 424, "start_date": "2013-11-25", "completion_date": "2015-01-19", "has_results": false, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-10-08T03:30:10.300Z", "location_count": 5, "location_summary": "Jacksonville, Florida • Stockbridge, Georgia • Boise, Idaho + 2 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Stockbridge", "state": "Georgia" }, { "city": "Boise", "state": "Idaho" }, { "city": "Erie", "state": "Pennsylvania" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01999842" }, { "nct_id": "NCT00408109", "title": "Safety Study of Avian Flu Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza A Virus, H5N1 Subtype", "Influenza A Virus", "Influenzavirus A", "Orthomyxoviridae", "H5N1 Virus" ], "interventions": [ { "name": "VRC-AVIDNA036-00-VP", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 45, "start_date": "2006-12-04", "completion_date": "2008-08-28", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-10-08T03:30:10.300Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00408109" } ] }